Clinical Trial Update: The Interest of the Nitrous Oxide During Intravesical Injection of Botulinum Toxin A [Phase 3]

View source ↗

Summary

This report covers a Phase 3 trial evaluating nitrous oxide as an analgesic aid during intravesical injections of botulinum toxin A. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Overactive Bladder

Drugs mentioned

• Nitrous oxide (nitrous oxide)
• OnabotulinumtoxinA (Botox) (Botulinum toxin type A)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Injection Site Vesicles | Phase 3 | Status: COMPLETED